NO971832L - Orale formuleringer med forlenget frigivelse inneholdende cisaprid - Google Patents

Orale formuleringer med forlenget frigivelse inneholdende cisaprid

Info

Publication number
NO971832L
NO971832L NO971832A NO971832A NO971832L NO 971832 L NO971832 L NO 971832L NO 971832 A NO971832 A NO 971832A NO 971832 A NO971832 A NO 971832A NO 971832 L NO971832 L NO 971832L
Authority
NO
Norway
Prior art keywords
release formulations
formulations containing
oral extended
containing cisapride
cisapride
Prior art date
Application number
NO971832A
Other languages
English (en)
Other versions
NO312538B1 (no
NO971832D0 (no
Inventor
Eugene Marie Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971832L publication Critical patent/NO971832L/no
Publication of NO971832D0 publication Critical patent/NO971832D0/no
Publication of NO312538B1 publication Critical patent/NO312538B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO19971832A 1994-11-02 1997-04-21 Orale formuleringer med forlenget frigivelse inneholdende cisaprid NO312538B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (3)

Publication Number Publication Date
NO971832L true NO971832L (no) 1997-04-21
NO971832D0 NO971832D0 (no) 1997-04-21
NO312538B1 NO312538B1 (no) 2002-05-27

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971832A NO312538B1 (no) 1994-11-02 1997-04-21 Orale formuleringer med forlenget frigivelse inneholdende cisaprid

Country Status (29)

Country Link
US (2) US6153623A (no)
EP (1) EP0789572A1 (no)
JP (1) JP3182423B2 (no)
KR (1) KR100255521B1 (no)
AP (1) AP658A (no)
AR (1) AR001765A1 (no)
AU (1) AU704284B2 (no)
BG (1) BG63244B1 (no)
BR (1) BR9509565A (no)
CA (1) CA2203663C (no)
CZ (1) CZ287844B6 (no)
EE (1) EE03510B1 (no)
FI (1) FI971856L (no)
HR (1) HRP950539A2 (no)
HU (1) HUT77887A (no)
IL (1) IL115843A0 (no)
MY (1) MY113092A (no)
NO (1) NO312538B1 (no)
NZ (1) NZ295166A (no)
OA (1) OA10419A (no)
PL (1) PL181470B1 (no)
RO (1) RO116042B1 (no)
RU (1) RU2143890C1 (no)
SK (1) SK54297A3 (no)
TR (1) TR199501351A2 (no)
TW (1) TW466114B (no)
UA (1) UA50721C2 (no)
WO (1) WO1996014070A1 (no)
ZA (1) ZA959221B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
CA2232489A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
EP0951278A2 (en) * 1997-01-03 1999-10-27 ELAN CORPORATION, Plc Sustained release cisapride mini-tablet formulation
JP2002504107A (ja) * 1997-06-11 2002-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （＋）−または（−）−シサプリドの即時放出性ｐＨ非依存的固形投薬剤形
TW407058B (en) 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
CO5140079A1 (es) * 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
EP1169024B1 (en) 1999-03-31 2005-12-21 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
CZ20021076A3 (cs) * 1999-09-28 2002-08-14 Panacea Biotec Limited Prostředky s kontrolovaným uvolňováním obsahující nimesulid
ATE361060T1 (de) * 2000-09-29 2007-05-15 Solvay Pharm Bv Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
DE60228939D1 (de) * 2002-05-21 2008-10-30 Watson Lab Inc Pharmazeutische Zusammensetzung mit verzögerter Freisetzung
EP2005946B1 (en) 2006-04-12 2015-11-18 Nippon Soda Co., Ltd. Method for producing extended release tablet
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
ES2124303T3 (es) * 1992-03-25 1999-02-01 Depomed Inc Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.
EP1145715A3 (en) * 1992-07-07 2004-05-19 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
AP658A (en) 1998-08-17
SK54297A3 (en) 1997-10-08
CA2203663A1 (en) 1996-05-17
AU3844795A (en) 1996-05-31
AR001765A1 (es) 1997-12-10
RU2143890C1 (ru) 2000-01-10
EE9700105A (et) 1997-12-15
CA2203663C (en) 2002-04-30
MY113092A (en) 2001-11-30
EE03510B1 (et) 2001-10-15
NO312538B1 (no) 2002-05-27
TW466114B (en) 2001-12-01
BG63244B1 (bg) 2001-07-31
CZ124497A3 (en) 1997-08-13
KR100255521B1 (ko) 2000-05-01
US6153623A (en) 2000-11-28
TR199501351A2 (tr) 1996-06-21
NO971832D0 (no) 1997-04-21
JPH09511760A (ja) 1997-11-25
BG101401A (bg) 1997-12-30
AP9700969A0 (en) 1997-04-30
PL181470B1 (pl) 2001-07-31
NZ295166A (en) 1999-03-29
FI971856A0 (fi) 1997-04-30
OA10419A (en) 2001-12-06
AU704284B2 (en) 1999-04-15
US6274599B1 (en) 2001-08-14
ZA959221B (en) 1997-04-30
CZ287844B6 (en) 2001-02-14
HUT77887A (hu) 1998-09-28
MX9703249A (es) 1997-07-31
JP3182423B2 (ja) 2001-07-03
FI971856A7 (fi) 1997-04-30
EP0789572A1 (en) 1997-08-20
FI971856L (fi) 1997-04-30
WO1996014070A1 (en) 1996-05-17
BR9509565A (pt) 1997-09-16
PL319948A1 (en) 1997-09-01
HRP950539A2 (en) 1997-08-31
RO116042B1 (ro) 2000-10-30
IL115843A0 (en) 1996-01-31
UA50721C2 (uk) 2002-11-15

Similar Documents

Publication Publication Date Title
FI963421A7 (fi) Oraalisia apuainekoostumuksia
DE69518331D1 (de) Orale zubereitungen
BR9507862A (pt) Escova dental
DE69516018D1 (de) Verdickte persäurezusammensetzungen
PT769965E (pt) Formulacoes aquosas de risperidona
BR9506536A (pt) Composição oral
DE69533129D1 (de) Zahnimplantat
FI916053A7 (fi) Oraalinen koostumus hammaskiveä vastaan
FI950402A7 (fi) Oraaliset koostumukset
BR9510467A (pt) Composições orais
NO971832D0 (no) Orale formuleringer med forlenget frigivelse inneholdende cisaprid
BR9510307A (pt) Composições orais
ATA65293A (de) Zahnärztlicher artikulator
KR970703779A (ko) 건강 조성물(health composition)
DE69521906D1 (de) Zahnhygiene - präparate
DE59205779D1 (de) Zahnärztliches handstück
DE69432149D1 (de) Orale Zubereitungen
ATA194094A (de) Artikulator
DE69519043D1 (de) Dentalgerät
ATA183891A (de) Zahnaerztliches handstueck
ATA117494A (de) Dentales handstück
DE69420258D1 (de) Zahnimplantat
BR9510459A (pt) Composições orais
ATA65393A (de) Zahnärztlicher artikulator
ATA241794A (de) Zahnärztliches handstück

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees